Skip to main content


Fig. 2 | BMC Musculoskeletal Disorders

Fig. 2

From: Supervised neuromuscular exercise prior to hip and knee replacement: 12-month clinical effect and cost-utility analysis alongside a randomised controlled trial

Fig. 2

Cost effectiveness acceptability curves for incremental net monetary benefit to estimate the probability for the intervention being cost effective at conventional thresholds for willingness to pay. Health care perspective, Health Care Sector perspective (base-case analysis); Complete item response, only complete item response of the EQ-5D-3L included in the analysis; Health care & patients’ expenses, Health Care Sector and patients’ own expenses perspective; No adjustment for baseline, adjustments for baseline EQ-5D-3L scores were not included; Per-protocol, only patients attending 12 or more exercise sessions were included in the analysis

Back to article page